WHAT IS MIGRAINE - CONTROVERSY AND STALEMATE IN MIGRAINE PATHOPHYSIOLOGY

被引:17
作者
EDMEADS, J [1 ]
机构
[1] UNIV TORONTO,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
MIGRAINE PATHOPHYSIOLOGY; SEROTONIN RECEPTORS; NEUROPEPTIDES;
D O I
10.1007/BF01642898
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Theories of migraine pathophysiology have evolved from the realms of the supernatural into the scientific arena but their further evolution seems delayed by unproductive controversy about whether or not migraine is primarily a vascular or a neurological dysfunction. This conceptual deadlock needs to be transcended by thinking beyond the neural and vascular systems, and by identifying mechanisms that could affect both to produce the characteristic clinical phenomena of migraine. One theoretical model envisages 5-hydroxytryptamine (serotonin; 5-HT) as a link between the neural and vascular systems, with global alteration of serotonergic neurotransmission affecting not only these systems, but the gastrointestinal tract as well, with incidental reverberations on platelet function. Such altered serotonergic transmission might originate from altered 5-HT receptor dynamics, a molecular change in turn produced by genetic mechanisms. Recognition of the importance of 5-HT receptor function in migraine, most notably that agonists of 5-HT1 receptors abort acute migraine and that antagonists of 5-HT2 receptors prevent migraine, may lead to significant therapeutic advances. The possibility that the "trigeminovascular system" might be the end-stage mechanism that these serotonergic changes detonate to produce the painful reverberations of migraine headache is also important. Seeking ways to muffle these reverberations, or to insulate the system itself from the action of external influences (likely through further study of peptidergic transmission and receptors) might result in more drugs that will abort or prevent migraine.
引用
收藏
页码:S2 / S5
页数:4
相关论文
共 21 条
[1]  
ANTHONY M, 1969, RESEARCH CLINICAL ST, V2, P29
[2]   RELATIONSHIPS BETWEEN HEADACHE AND AMINE CHANGES AFTER ADMINISTRATION OF RESERPINE TO MIGRAINOUS PATIENTS [J].
CURZON, G ;
BARRIE, M ;
WILKINSO.MI .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1969, 32 (06) :555-&
[3]  
DANDREA G, 1982, HEADACHE, V22, P207
[4]   SEROTONIN-S2 RECEPTORS AND MIGRAINE - A STUDY WITH THE SELECTIVE ANTAGONIST ICI 169,369 [J].
DAVIES, PTG ;
STEINER, TJ .
HEADACHE, 1990, 30 (06) :340-343
[5]   PLATELET-RELEASE REACTION DURING MIGRAINE ATTACKS [J].
GAWEL, M ;
BURKITT, M ;
ROSE, FC .
HEADACHE, 1979, 19 (06) :323-327
[6]   Mechanism of migraine headache and action of ergotamine tartrate [J].
Graham, JR ;
Wolff, HG .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1938, 39 (04) :737-763
[7]  
HANINGTON E, 1981, LANCET, V2, P720
[8]   5-HYDROXYTRYPTAMINE LEVELS AND PLATELET AGGREGATION RESPONSES IN SUBJECTS WITH ACUTE MIGRAINE HEADACHE [J].
HILTON, BP ;
CUMINGS, JN .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1972, 35 (04) :505-&
[9]   ANTI-MIGRAINE DRUGS IN DEVELOPMENT - ADVANCES IN SEROTONIN RECEPTOR PHARMACOLOGY [J].
HUMPHREY, PPA ;
FENIUK, W ;
PERREN, MJ .
HEADACHE, 1990, 30 :12-16
[10]   EFFECT OF SEROTONIN IN MIGRAINE PATIENTS [J].
KIMBALL, RW ;
FRIEDMAN, AP ;
VALLEJO, E .
NEUROLOGY, 1960, 10 (02) :107-111